Valuation: Gland Pharma Limited

Market Cap 392B 4.05B 3.56B 3.31B 3.04B 5.7B 5.8B 39.52B 15.42B 191B 15.19B 14.86B 663B P/E 2026
27.2x
P/E 2027 * 31.4x
Enterprise Value 363B 3.74B 3.29B 3.06B 2.81B 5.28B 5.37B 36.59B 14.27B 177B 14.06B 13.75B 614B EV / Sales 2026
3.86x
EV / Sales 2027 * 4.84x
Free-Float
48.23%
Yield 2026
1.18%
Yield 2027 * 0.82%
1 day-2.52%
1 week-6.00%
Current month-4.70%
1 month+3.46%
3 months+32.43%
6 months+41.32%
Current year+38.08%
1 week 2,351.1
Extreme 2351.1
2,497.9
1 month 2,299.2
Extreme 2299.2
2,573.5
Current year 1,573.6
Extreme 1573.6
2,573.5
1 year 1,573.6
Extreme 1573.6
2,573.5
3 years 1,190
Extreme 1190
2,573.5
5 years 861
Extreme 861
4,350
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap.
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 2,000 0.0012%
6/28/24 Sell 1,000 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%-6.00%+16.67%+92.43% 4.16B
+1.97%+1.43%+48.44%+156.66% 1,037B
+1.42%+3.72%+53.32%+52.34% 615B
+1.43%+0.99%+34.83%+78.74% 448B
+5.14%+5.40%+33.75%+27.28% 326B
+1.85%+3.57%+37.09%+39.87% 293B
-0.11%+0.48%+18.87%+17.81% 264B
+0.25%-4.62%-27.66%-42.25% 216B
+1.49%-0.02%+20.14%+58.21% 198B
+0.40%-3.99%+15.23%+62.28% 162B
Average +1.13%+0.16%+25.07%+54.34% 356.16B
Weighted average by Cap. +1.73%+1.12%+35.38%+75.25%

Financials

2026 2027 *
Net sales 63.44B 655M 576M 535M 492M 923M 940M 6.4B 2.5B 30.94B 2.46B 2.41B 107B 73.29B 757M 666M 618M 569M 1.07B 1.09B 7.39B 2.88B 35.75B 2.84B 2.78B 124B
Net income 9.36B 96.66M 85.01M 78.97M 72.63M 136M 139M 944M 368M 4.57B 363M 355M 15.84B 12.47B 129M 113M 105M 96.76M 181M 185M 1.26B 491M 6.08B 483M 473M 21.1B
Net Debt -29.08B -300M -264M -245M -226M -423M -431M -2.93B -1.14B -14.19B -1.13B -1.1B -49.22B -37.3B -385M -339M -315M -289M -543M -553M -3.76B -1.47B -18.19B -1.45B -1.41B -63.12B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,351
Date Price Change Volume
26-07-23 ₹2,377.70 -2.52% 197,918
26-07-22 ₹2,439.10 -1.74% 671,215
26-07-21 ₹2,482.40 +0.95% 210,888
26-07-20 ₹2,459.10 +0.41% 324,971
26-07-17 ₹2,449.00 -3.18% 326,961
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,377.70INR
Average target price
2,286.00INR
Spread / Average Target
-3.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock